Data suggest that the currently available therapies for erectile dysfunction (ED) do not meet all the patients' and their partners' expectations. The aim was to assess ED patients' treatment expectations for a variety of sex-and drug-related aspects such as importance of spontaneity, partner satisfaction, ideal onset of action and ideal duration of action. A total of n = 1124 men with ED and n = 410 healthy men, aged 30-75, participated in this online survey. The ED sample was further divided into patients currently undergoing treatment (CTG), patients who had been undergoing treatment in the past (PTG) and naïve patients (NG). The International Index of Erectile Function as well as a mix of study-specific questions was used. All groups considered 'maintaining an erection until the partner reaches orgasm' the most important aspect regarding erectile function. 'Being able to please the partner' was considered as the most important aspect for a fulfilled sex life. The majority of men (38.1%) further considered an onset of action of about 15 min to be desirable. In all, 95.9% further considered a duration of action up to 4 h to be desirable whereas approximately 71% of men considered a duration of more than 12 h to be too long. It seems that once the basic functional aspects related to erectile function have been covered, additional benefits such as 'spontaneity' and 'pleasing the partner' become important and may be critical for choosing the optimum individual treatment, to improve the sexual satisfaction and the adherence to the treatment.
INTRODUCTION
Sexuality represents a key domain and a very important bonding aspect in most relationships, regardless of the partners' sexual orientation. Even in the elderly population an active sex life has been reported to be an important factor for nearly half of men aged 75-95, according to a population-based cohort study (n = 3274) conducted in Australia. 1 Numerous studies have provided convincing evidence that in many elderly men sexual health deteriorates, with the decline usually starting in the 5th life decade and progressively increasing as a function of age. 2 This statement is generally true for all aspects of male sexual functioning, including sexual desire, sexual arousal, erectile function and ejaculatory/orgasmic capacity, but applies especially to erectile function. 2 Erectile dysfunction (ED), together with premature ejaculation (PE), is the most common male sexual disorder. The largest follow-up study published on the prevalence of ED comprised 108 477 men aged 45 years or older, recruited between 2006 and 2010. 3 In this population sample, only 39.31% of men reported not suffering from ED, whereas 25.14% had mild ED (that is, experienced ED sometimes), 18 .79% moderate ED (that is, usually experienced) and 16 .77% complete ED. 3 Moreover, recent studies provide evidence that ED is also a common problem among younger men. In a recently conducted Italian study, one male patient out of four with a newly diagnosed ED was below 45 years of age. 4 Sexual problems, such as ED, not only negatively affect the patient's self-esteem, quality of life and emotional status, but also heavily impact the partner's sexuality and can consequently jeopardize relationship quality and stability. [5] [6] [7] [8] Very often these feelings are exacerbated by the social stigma of ED.
At present, the variety of treatment options for ED available, frequently allow a successful management of ED, and indirectly also contribute to the improvement of the patients' selfconfidence and quality of life, as well as the partner's sexual satisfaction, ultimately improving the harmony and stability of their relationship. 9 In all relevant current guidelines of the medical societies dealing with sexual medicine, phosphodiesterase-5 (PDE-5) inhibitors are unanimously listed as first-line therapy for ED. Reported efficacy rates when relying on objective endpoints such as successfully completed intercourse range from about 60% to 70% in broad-spectrum ED populations. [9] [10] [11] A review and metaanalysis of the literature considering all prospective randomized, placebo-controlled and double-blinded studies showed that after successful ED treatment significant improvements could also be observed for quality of life, sexual satisfaction, self-confidence, self-esteem and symptoms of depression. 5 However in spite of their recognized effectiveness, there is still a non-negligible number of patients who discontinue PDE-5 inhibitor therapy, because of either personal or their partners sexual dissatisfaction with the chosen treatment. [12] [13] [14] Overall, reasons for discontinuation vary including medication being too expensive, noneffectiveness of PDE-5 inhibitors, or expectations not being met -which may include erection hardness and ability to maintain erection through intercourse completion, partner satisfaction, naturalness of erection or timing issues such as rapidity of onset of action, or duration of action-, as well as safety concerns and tolerability issues. [12] [13] [14] Overall, present data suggest drop-out rates of up to 50% after a 2-year follow-up, with current ED treatment. It is therefore of major importance to better understand which are the patients' and sexual partners' needs and expectations with ED treatment, and why so many are finally dissatisfied with the currently available treatment modalities, especially regarding the first-line oral drug therapy with PDE-5 inhibitors.
Therefore, the aim of this study was to assess ED patients' treatment needs and expectations for a variety of sex-and drugrelated aspects such as importance of spontaneity and naturalness of the encounter, partner satisfaction, multiple episodes within one sexual encounter, ideal onset of action, as well as ideal duration of effects.
MATERIALS AND METHODS

Sample and recruitment
The study was conducted by a market research company in 2014 targeting male members belonging to an online consumer panel on 'Men's Health Condition'. All individuals were contacted via email and two reminders were sent to the non-responders during the 14-day period of data collection. Quotas were assigned to capture 80% of men suffering from ED-including 33% currently treated patients, 33% past treated patients and 33% naïve patients-and 20% healthy men (HG). Assignment to the three patient or healthy participant groups was based on the shortened International Index of Erectile Function version (IIEF-5) scores, using a cutoff score of 421. 15 Of the large number of panel members contacted, 1.19% filled in the full questionnaire and 1.2% abandoned the questionnaire, resulting in n = 2276 individuals with full data. To be eligible to participate in this survey, participants had to meet the following key inclusion criteria: 30-75 years of age, sexually active, considering themselves of exclusively or predominantly heterosexual orientation. Furthermore, men reporting spinal cord injuries or having undergone non-nerve sparing radical prostatectomy were excluded from the study (n = 2, 0.13%). In the end, 1534 participants met all inclusion criteria. The previously set quotas were not entirely met, resulting in 73.3% men with ED and 26.7% healthy men (HG). The sample of 1124 men with ED was further divided into 25.7% who were undergoing ED treatment at the time of recruitment (current treatment group, CTG); 26.4% who had undergone ED treatment in the past (past treatment group, PTG); and 47.9% who had never sought ED treatment (naïve group; NG; Table 1 ).
Informed consent was provided by each individual while registering to the panel. Because of the non-interventional design of this online survey ethical approval was not needed.
Material
For this survey, the IIEF-5 together with a set of study-specific, self-constructed questions were used. 15 The five IIEF item focuses on sexual experiences within the past 6 months that include questions on erectile function, and intercourse satisfaction. Items are scored on a 6-point Likert-type scale, offering a supplementary option 'no sexual activity'. Higher scores indicate better sexual functioning. The IIEF-5 has demonstrated high retest reliability, good internal consistency (Cronbach's α ranging from 0.70 to 0.90) and good sensitivity and specificity for detecting treatment-related changes with a score between 21 and 25 indicating normal erectile function and scores between 5 and 20 ED severe (score 5-7), moderate (score 8-11), mild to moderate (score 12-16) and mild (score 17-21). 15 Cronbach's α for the current study was 0.89.
The following self-constructed questions were used to assess aspects related to treatment expectancy and needs: 'Are you undergoing any treatment for your erectile problems?'; 'How important do you consider the following aspects for a fulfilled/satisfied sex life?'; 'In terms of your erectile function, how important do you consider the following aspects?'; 'To what extent do each of the following aspects related to your erectile problem bother you/make you dissatisfied'; 'How important do you consider the following aspects about an ED treatment'; 'How ideal do you consider the following onsets of action of the treatment?'; 'Do you consider this time of onset ideal because...?'; 'How ideal do you consider the following duration of action?'; 'Do you consider this duration of action ideal because...?'. Response options for the various aspects (for example, partner satisfaction and maintenance of erection) were on a 5-point Likert-type scale ranging from 'not at all' to 'very much'. Questions relating to onset of action after intake and ideal duration offered four different time period options, with 'about 15 min'; '15-30 min'; 'between 30 and 1 h'; 'over 1 h' for onset of action and 'up to 4 h'; 'between 4 and 6 h'; 'between 6 and 12 h'; 'over than 12 h' for duration of action. The 4-point response options for these two questions ranged from 'too short' to 'too long'.
Statistical analyses
For the data management STATA (Version 10.0, 2008, StataCorp, College Station, TX, USA) was used. To examine the relationship between the variables, a set of correlation analyses were conducted, including pointbiserial correlations (r pb ) for dichotomous and continuous variables, Spearman correlations (r s ) for categorical and continuous variables, and Pearson correlations (r p ) for continuous variables. For group comparisons, univariate Kruskal-Wallis analyses (non-parametric test, equivalent to ANOVA) were calculated by comparing the means of our variables of interest. Bonferroni corrected, multiple sample contrasts were performed post hoc to these analyses. All tests were two-tailed. For all analyses, a P-value of less than 0.05% was considered as statistically significant, unless stated otherwise.
RESULTS
The final sample consisted of 1534 individuals with a mean age of 46 years (s.d. ± 10.9; range 30-75; Table 1 ). In all, 73% (n = 1124) of the study sample had a history of ED, with 47% (n = 529) of them never having been treated for their ED (that is, naive patients). The majority of patients suffered from mild ED (38.46), whereas only 17 individuals (1.11%) showed symptoms of severe ED (Table 1 ). Average ED duration was 49 months (s.d. ± 42.5, range 1-480 months). The different ED groups did not differ significantly in any of the socio-demographic variables or in ED duration. The most prevalent sexual comorbidity was self-reported PE (22.6%), followed by low libido (18.2%). Almost a fifth of men further reported suffering from high blood pressure (19.6%), as well as from high cholesterol (17.3%), and from diabetes (11.5%; Table 1 ). In terms of psychological comorbidities, co-occurring anxiety and depression were the most frequent complaints (16.9 and 12.3%). Regarding medical, psychological and sexual comorbidities, the healthy group consistently showed the lowest prevalence rates for all diseases ( Table 1) .
Importance of sex for men
The majority of men found sex either important (40.55%) or very important (37.48%; response options ranging from 1 'not important at all' to 6 'very important'; Table 2 ). These findings were independent of age (P = 0.24). ED men-independent of whether or not they were or had been treated-considered sex slightly less important (Pearson χ 2 (5) = 11.17, P = 0.048) compared with their healthy counterparts ( Table 2) . Within the ED sample, a significant difference in importance of sex could be detected between the CTG and the NG, with the latter considering it significantly less important; χ 2 = 10.15, P = 0.02.
Importance of aspects related to erectile function
Overall, men across all ED groups and in the healthy group considered 'maintaining an erection until the partner reaches orgasm' the most important aspect regarding sexual intercourse. The least important was 'allowing for multiple episodes within one sexual encounter' ( Table 2 ). There were significant differences regarding the priority of the various aspects across the groups, with the naïve patients (NG) considering all aspects significantly less important compared with the CTG and the PTG as well as the healthy individuals (Table 2 ). An age effect could be detected for 'multiple episodes' and 'maintaining an erection until the partner reaches orgasm', with higher prioritization rates of the first aspect (r = − 0.15, P o0.001) in younger men whereas with increasing age the latter was considered more important (r = 0.08, P = 0.006; data not shown). Aspects of importance for a fulfilled sex life Overall, 'being able to please the partner', as well as 'feeling pleasure' and 'partner involvement' were considered as the most important aspects for a fulfilled sex life, whereas 'not having to plan' and 'engaging in sex whenever he wants' were considered as less important (Table 2 ). Similar to aspects related to erectile function, all aspects were considered as more important by the healthy individuals, compared with men suffering from ED. Within the ED sample, men of the naïve patient group considered all aspects less important compared with their treated counterparts ( Table 2) . Again, age effects were observed for younger men considering spontaneity more important (r p = − 0.06, P o0.05), as well as 'engaging whenever the partner wants to' (r p = − 0.61, Po 0.05).
Ideal onset of action
Overall, the majority of men (38.1%) considered an onset of action of 'about 15 min' desirable, whereas for 27.6% it was somewhere 'between 15 and 30 min', and for 34.4% 'between 30 and 60 min' (Figure 1 ). None of the respondents considered an onset of 'more than 60 min' to be adequate or desirable. As shown in Figure 1 , for men across all three ED groups an onset of action of 'about 15 min' was considered desirable with the ED groups not differring significantly in their overall evaluation. The reasons for considering an onset of action 'about 15 min' desirable, as well as their relative importance, are depicted in Overall, the reasons were rated as being of similar importance, although 'not having to spend much time on foreplay' was clearly considered as the least important aspect, whereas 'it allows a certain degree of spontaneity' and 'it allows to respond immediately to the partner's wishes' were rated the most important reasons.
Ideal duration of action
The clear majority of men across all ED groups (95.91%) considered a duration of up to 4 h to be desirable (Figure 3 ) and 47.69% of men considered 6-12 h to be adequate. Approximately 71% of men considered as a duration of more than 12 h to be too long (Figure 4 ). The three ED groups did not differ significantly in their evaluation of the ideal duration of action or what they considered as too long (Figures 3 and 4) .
DISCUSSION
This survey assessed patients' treatment expectations regarding ideal onset of action and ideal duration of effects, as well as the importance of a variety of factors associated with erectile function and demands regarding a satisfying sex life. In summary, the majority of men considered an onset of action of about 15 min to be desirable or ideal because that 'allows a certain degree of spontaneity' and 'it allows responding immediately to the partner's wishes'. Overall, naïve patients considered aspects related to sexuality and erectile function as less important compared with currently or past treated patients, as well as healthy males.
Recent study findings pointed to the fact that a large proportion of men undergoing pharmacological treatment for ED discontinue treatment prematurely, indicating that currently available therapies do not meet patient and partner expectations in a significant number in terms of erection hardness, confidence, naturalness, fast onset and duration of effects, respectively. 14 It is therefore crucial to understand the real patients' wishes and expectations and which factors bother them most in relation to their current condition to find an optimal treatment choice tailored to the individual needs.
Regarding erectile function, the most important aspect for men with ED and also healthy men was to be able to obtain a spontaneous, that is, an immediate erection, and to maintain it until the patient and his sexual partner reaches orgasm. Being able to engage in multiple episodes within one sexual encounter was considered as least important by all groups. In other words, the basic functional aspects related to the ability to engage successfully in sexual intercourse satisfying both partners need to be covered. However, once these basic needs are met, other aspects providing additional benefits become more important. Asking men what they considered important for a fulfilled sex life, the involvement of the partner and the ability to satisfy and please the partner were regarded most important by all groups, followed by preservation of a certain degree of spontaneity (defined as not having to plan) and thus the naturalness of the encounter as it used to be under normal life conditions. Such additional benefits -apart from basically functional aspects like rigidity and maintenance of erection-may finally make the difference in choosing the individual optimum treatment method and are primarily addressing the pharmacokinetic aspects of a substance in question, especially regarding onset and duration of action.
Overall, the majority of men (65.7%) considered an onset of action, that is, manifestation of a rigid erection suitable for sexual intercourse within 30 min important with 38.1% claiming 15 min to be desirable or ideal. The main arguments for such a quick onset were that it allows the spontaneity men and their partners usually have had in the past and hence, give the men the ability to respond immediately to the partner's sexual wishes and requests. The majority of men across all ED groups (69%) further considered a duration of up to 6 h to be desirable, whereas approximately 71% of men considered a duration of more than 12 h to be too long. These findings underline again the fact that once the basic functional aspects have been fixed successfully, other factors such as not having to plan the exact timing of the intercourse become more important. According to the present data, the combination of efficacy, a fast onset of action and a desirable or a reasonably long window of efficacy seem to be the key features for a modern ED treatment. In this context, it should be noted that a former study evaluating different aspects of the sexual life of couples with men suffering from ED provided evidence that for more than half of both the men and their female partners sexual activities occurred very spontaneously with 61% of the females and 52% of the males stating that they are never aware in advance that sex may happen. 16 With these figures in mind pharmacokinetic features of a modern ED drug and hereby especially a rapid onset of action coping with a natural and spontaneous sex life is an important aspect for the majority of couples beyond the wellestablished functional aspects.
In general, men suffering from ED-independent of whether or not they were or had been undergoing treatment-considered sex as slightly less important compared with their healthy counterparts. Among ED men, the naïve patients regarded sex as considerably less important compared with men who were or had been undergoing treatment. A similar picture could be verified for aspects related to a fulfilled sex life, as well as to erectile function (such as rigidity, pleasure and pleasing the partner), which were consistently considered less important by ED patients-and here especially by the naïve patients-in comparison with healthy individuals. The finding that ED patientsć onsider sex and related aspects as less important compared with healthy individuals could reflect the consequence or impact of ED, leading to some degree of emotional and cognitive dissonance. Accordingly, humans strive for internal consistency and when experiencing dissonance, become psychologically uncomfortable and attempt to reduce dissonance by means of coping strategies, such as changing their existing beliefs, ideas or values. 17, 18 Evaluation of importance of sex and aspects related to sexuality and erectile function, as well as ideal onset of action and duration of action was mostly independent of age. Interestingly, however, 'being able to engage in multiple episodes within one sexual encounter' and 'spontaneity' were considered as more important by younger men, whereas with increasing age men assigned more importance to 'maintaining an erection until the partner reaches orgasm'.
Limitations
As is the case with all surveys of this nature, there are several strengths and potential limitations to the research design. First, our data might have been affected by biases, such as reporting biases given the sensitive nature of the questions. Second, the response rate of 1.2% is very small compared with other epidemiologic research studies but comparable to studies using large consumer panels. Third, a high rate of comorbid mental and sexual problems was reported in our study sample. Ideally, future studies should carefully explore the effects, especially of depression or hyposexual desire disorder, on for example how important men rate sexuality and erectile function-related aspects. Although not a study limitation per se, it is important to mention that men from different countries were included in the study. While beyond the scope of this study, potential cultural differences in men's sexual preferences and treatment expectations should be more carefully investigated and reported in a future study.
CONCLUSION
This survey shows that once basic functional aspects related to erectile function, such as getting and maintaining an erection for a successful sexual intercourse, are satisfied, additional benefits such as rapid onset of action coping with a natural and thus spontaneous sex life as wished by the majority of couples as well as 'pleasing the partner' become the most important elements and make the difference in choosing the optimum treatment. A fast onset of action of about 15 min and a duration of less than 12 h seem to be prioritized by men suffering from ED to meet their most dominant wishes and expectations finally improving the satisfaction of sexual life and the adherence to the chosen treatment.
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